Zobrazeno 1 - 10
of 11
pro vyhledávání: '"O. I. Kaganov"'
Publikováno v:
Креативная хирургия и онкология, Vol 11, Iss 1, Pp 5-9 (2021)
Background. Breast cancer (BC) is distinguished with its biological tumour subtypes as luminal A, B, HER2-positive and triple-negative. The current clinical guidelines of the Russian Ministry of Health prescribe neoadjuvant targeted chemotherapy as c
Externí odkaz:
https://doaj.org/article/312f4805d06f498abad4a5c4ca18d1e5
Patient blood management in oncology in the Russian Federation: resolution to improve oncology care.
Autor:
A. Hofmann, M. Aapro, T. A. Fedorova, Ye. B. Zhiburt, A. V. Snegovoy, O. I. Kaganov, N. A. Ognerubov, V. K. Lyadov, V. M. Moiseenko, O. P. Trofimova, L. A. Ashrafyan, R. Sh. Khasanov, I. V. Poddubnaya
Publikováno v:
Современная онкология, Vol 22, Iss 3, Pp 59-78 (2020)
The huge global burden of oncological diseases is growing and measures to counter this complex challenge are high on national health agendas. The Russian National Long-Term Oncology Strategy 2030 defines priorities, goals and directions in the fight
Externí odkaz:
https://doaj.org/article/76459e8aa09847f3aab7dc006681d2be
Publikováno v:
Parodontologiya. 27:227-233
Relevance. The prevalence of oral mucosal diseases among the Russian population varies from 3% to 20% [7]. Precancerous and malignant diseases are a particular problem. More than nine thousand new cases of malignant oral mucosal lesions are registere
Publikováno v:
Креативная хирургия и онкология, Vol 11, Iss 1, Pp 5-9 (2021)
Background. Breast cancer (BC) is distinguished with its biological tumour subtypes as luminal A, B, HER2-positive and triple-negative. The current clinical guidelines of the Russian Ministry of Health prescribe neoadjuvant targeted chemotherapy as c
Autor:
D. A Trunin, AM Khamadeeva, DA Eremin, M A Postnikov, V. P. Kirillova, IS Kopetskiy, O I Kaganov, A.G. Gabrielyan, OV Osokin
Publikováno v:
Features of HIV and SARS-CoV-2 coinfection in a pandemic. :65-71
The search for and the application of available noninvasive methods for early diagnosis of oral mucosa (OM) neoplasia is a clinically significant problem. The aim of this study was to evaluate the effectiveness of the original score-based algorithm f
Autor:
N.A. Ognerubov, O. I. Kaganov, V. K. Lyadov, A. V. Snegovoy, M. Aapro, T. A. Fedorova, Lev A. Ashrafyan, O. P. Trofimova, V. M. Moiseenko, I. V. Poddubnaya, R Sh Khasanov, Ye. B. Zhiburt, Axel Hofmann
Publikováno v:
Современная онкология, Vol 22, Iss 3, Pp 59-78 (2020)
The huge global burden of oncological diseases is growing and measures to counter this complex challenge are high on national health agendas. The Russian National Long-Term Oncology Strategy 2030 defines priorities, goals and directions in the fight
Publikováno v:
Science and Innovations in Medicine. 3:49-53
Aim - determination of RFTA place in the combined treatment of bilobar liver metastatic process of colorectal cancer. Materials and methods. 176 patients with colorectal cancer with multiple (more than 4) bilobar liver metastases were included in the
Publikováno v:
Science and Innovations in Medicine. 3:54-59
Aim - to improve the long-term results of cytoreductive treatment of patients with simultaneous multiple bilobar liver metastases of colorectal cancer by the use of RFTA. Materials and methods. The study presents the results of treatment of 168 patie
Autor:
M. O. Vozdvizhensky, O. I. Kaganov, A. E. Orlov, S. V. Kozlov, A. P. Borisov, M. V. Tkachev, V. N. Saveliev
Publikováno v:
Biomedical Engineering. 52:156-158
A device for mobilization of the greater pectoral muscle during endoprosthetic surgery was developed at the Samara Regional Clinical Oncology Center (Utility model patent No. 175229; November 28, 2017). The device makes the surgery less traumatic, re
Autor:
I. A. Batrachenko, S. V. Kozlov, N. V. Blinov, A. A. Moryatov, O. I. Kaganov, A. E. Orlov, D. N. Artemiev, V P Zaharov
Publikováno v:
AIP Conference Proceedings.
Skin melanoma is spread inhomogeneously worldwide, particularly in Samara region there are high figures of skin neoplasms sick rate as well—18.6%. Research goal: to develop a new method of early non-invasive differential diagnostics of skin neoplas